OPKO Health (OPK) EV/EBITDA Multiple

OPKO Health Corp. (OPK) - corporate logo

OPKO Health, Inc. (OPK) is advancing personalized medicine through partnerships with pharmaceutical behemoths. The GURU.Markets terminal displays a chart of the company's EV/EBITDA fluctuations, where 0.00 indicates the current level. To restore profitability amid pressure from networks, the business is restructuring its laboratories, leveraging R&D in precision diagnostics and the development of targeted drugs for early disease detection.

OPK OPKO Corp: Total Company Value to Operating Income Before Depreciation Ratio in the range 11/23/2025 - 11/12/2026

Financial and market metric breakdowns for opko.com (OPK)

- market price and analyst price targets:
Price Chart OPKO Corp|OPK - Analyst Median Target
- market capitalization details:
Market Capitalization OPKO Health Corp.|OPK - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share OPKO Health|OPK - Book Valuation of Business|Market Value to Book Value Ratio opko.com|OPK - Company Assets
- company liabilities and liquidity data:
Debt to Equity OPKO Health, Inc.|OPK - Long-Term Liabilities to Equity|Short-Term Debt to Equity OPKO Health|OPK - Company Aggregate Debts|Debt to Book Capitalization Ratio OPKO Health Corp.|OPK - Long-Term Debt|Company Current Liabilities OPKO Health|Quick Ratio opko.com
- business earnings and investment ratios data:
OPK - Final Profit|Projected Future Earnings OPKO Health, Inc.|OPK - Market Cap to Earnings|Forward P/E Multiple OPKO Health, Inc.|OPK - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OPKO Health Corp.|OPK - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months OPKO Health|OPK - Earnings per share for the last four quarters|Quarterly EPS earnings growth opko.com|OPK - Earnings per share increase in current year|Expected earnings per share growth for next year OPKO Health, Inc.
Fundamental company analysis:OPK (OPKO Corp)
Original product of OPKO Health

This indicator compares the total enterprise value to its operating profit before depreciation and amortization, allowing for an asset valuation independent of tax regimes and debt loads. By analyzing the EV/EBITDA multiple alongside the capital structure, an investor gains insight into the real value of OPKO Health, Inc. (OPK), where the vertical integration of laboratories and biotech mitigates dependence on rigid insurance tariffs.

Competitor analysis

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Agilent Tech A|Total Company Value to Operating Income Before Depreciation Ratio Quest Corp (DGX)|Illumina, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|Revvity (RVTY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Company Value to EBITDA Nordion SHC|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization QuidelOrtho (QDEL)|CDNA: Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Maravai LifeSciences Holdings, Inc. MRVI|EV/EBITDA Multiple Fulgent Genetics Inc FLGT|LAB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Cytek Corp|OSUR (OraSure Technologies) - Enterprise Value to EBITDA Ratio|Exagen - Business Value to Operating Income Before Depreciation|MDXH (MDxHealth) - EV/EBITDA Multiple|LUCD: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple PRE|IMDX - Company Value to EBITDA|EV/EBITDA Multiple TRIB (Trinity Biotech)|EV/EBITDA Multiple prophaselabs.com PRPH|AIMD - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CODX: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HSCS (Heart Test Laboratories Inc.) - Enterprise Value to EBITDA Ratio|BMRA: Enterprise Value to Operating Income Before Depreciation Ratio|CDIO (Cardio Diagnostics Holdings Inc.) - EV/EBITDA Multiple|ONCO: Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio VRAX (Virax Biolabs)|BJDX (Bluejay Diagnostics Inc) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AWH (Vermillion)|Total Company Value to Operating Income Before Depreciation Ratio Accelerate Diagnostics Inc (AXDX)|CNTG - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ENZ (Enzo Biochem, Inc.) - Enterprise Value to Operating Income Before Depreciation|FRES: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Genetic Technologies Limited|Enterprise Value to EBITDA Ratio ME|Psychemedics Inc (PMD) - Total Company Value to Operating Income Before Depreciation Ratio